Efficacy of N-methyl-D-aspartate receptor modulator augmentation in schizophrenia: A meta-analysis of randomised, placebo-controlled trials
出版年份 2021 全文链接
标题
Efficacy of N-methyl-D-aspartate receptor modulator augmentation in schizophrenia: A meta-analysis of randomised, placebo-controlled trials
作者
关键词
-
出版物
JOURNAL OF PSYCHOPHARMACOLOGY
Volume -, Issue -, Pages 026988112096593
出版商
SAGE Publications
发表日期
2021-01-14
DOI
10.1177/0269881120965937
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Glutamate and Dysconnection in the Salience Network: Neurochemical, Effective-connectivity, and Computational Evidence in Schizophrenia
- (2020) Roberto Limongi et al. BIOLOGICAL PSYCHIATRY
- Dopamine and glutamate in schizophrenia: biology, symptoms and treatment
- (2020) Robert A. McCutcheon et al. World Psychiatry
- Glutamatergic neurometabolites and cortical thickness in treatment-resistant schizophrenia: Implications for glutamate-mediated excitotoxicity
- (2020) Parita Shah et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Glycine Signaling in the Framework of Dopamine-Glutamate Interaction and Postsynaptic Density. Implications for Treatment-Resistant Schizophrenia
- (2020) Andrea de Bartolomeis et al. Frontiers in Psychiatry
- Effect of N-methyl-D-aspartate-receptor-enhancing agents on cognition in patients with schizophrenia: A systematic review and meta-analysis of double-blind randomised controlled trials
- (2019) Chun-Hung Chang et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Targeted Treatment of Individuals with Psychosis Carrying a Copy Number Variant Containing a Genomic Triplication of the Glycine Decarboxylase Gene
- (2019) J. Alexander Bodkin et al. BIOLOGICAL PSYCHIATRY
- Methodological advantages and disadvantages of parallel and crossover randomised clinical trials on methylphenidate for attention deficit hyperactivity disorder: a systematic review and meta-analyses
- (2019) Helle B Krogh et al. BMJ Open
- The trim-and-fill method for publication bias
- (2019) Linyu Shi et al. MEDICINE
- Serum levels of TNF-alpha in patients with chronic schizophrenia during treatment augmentation with sarcosine (results of the PULSAR study)
- (2018) Dominik Strzelecki et al. PSYCHIATRY RESEARCH
- Neurophysiological Effects of Bitopertin in Schizophrenia
- (2017) Joshua T. Kantrowitz et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Sodium Benzoate, a D-Amino Acid Oxidase Inhibitor, Added to Clozapine for the Treatment of Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Trial
- (2017) Chieh-Hsin Lin et al. BIOLOGICAL PSYCHIATRY
- The effects of glycine on auditory mismatch negativity in schizophrenia
- (2017) Lisa-Marie Greenwood et al. SCHIZOPHRENIA RESEARCH
- Improvement in mismatch negativity generation during d-serine treatment in schizophrenia: Correlation with symptoms
- (2017) Joshua T. Kantrowitz et al. SCHIZOPHRENIA RESEARCH
- Association between serum levels of glutamate and neurotrophic factors and response to clozapine treatment
- (2017) Amir Krivoy et al. SCHIZOPHRENIA RESEARCH
- Targeting glutamate to treat schizophrenia: lessons from recent clinical studies
- (2016) Katherine Beck et al. PSYCHOPHARMACOLOGY
- Nature of Glutamate Alterations in Schizophrenia
- (2016) Kate Merritt et al. JAMA Psychiatry
- Glutamatergic Neurometabolites in Clozapine-Responsive and -Resistant Schizophrenia
- (2015) M. E. Goldstein et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- The Method Quality of Cross-Over Studies Involved in Cochrane Systematic Reviews
- (2015) Hong Ding et al. PLoS One
- Adjunctive sarcosine plus benzoate improved cognitive function in chronic schizophrenia patients with constant clinical symptoms: A randomised, double-blind, placebo-controlled trial
- (2015) Chun-Yuan Lin et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Initial Severity of Schizophrenia and Efficacy of Antipsychotics
- (2015) Toshi A. Furukawa et al. JAMA Psychiatry
- Glutamatergic agents for schizophrenia: current evidence and perspectives
- (2015) Mathias Zink et al. Expert Review of Clinical Pharmacology
- A double-blind, placebo-controlled comparator study of LY2140023 monohydrate in patients with schizophrenia
- (2014) AnnCatherine M Downing et al. BMC Psychiatry
- A phase II/III trial of bitopertin monotherapy compared with placebo in patients with an acute exacerbation of schizophrenia – Results from the CandleLyte study
- (2014) D. Bugarski-Kirola et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Changes in plasma d-serine, l-serine, and glycine levels in treatment-resistant schizophrenia before and after clozapine treatment
- (2014) Hidenaga Yamamori et al. NEUROSCIENCE LETTERS
- d-Cycloserine augmentation of cognitive remediation in schizophrenia
- (2014) Christopher K. Cain et al. SCHIZOPHRENIA RESEARCH
- Effect of Bitopertin, a Glycine Reuptake Inhibitor, on Negative Symptoms of Schizophrenia
- (2014) Daniel Umbricht et al. JAMA Psychiatry
- Placebo Response in Antipsychotic Clinical Trials
- (2014) Bret R. Rutherford et al. JAMA Psychiatry
- The Impact of Study Size on Meta-analyses: Examination of Underpowered Studies in Cochrane Reviews
- (2013) Rebecca M. Turner et al. PLoS One
- Negative symptoms in schizophrenia – the remarkable impact of inclusion definitions in clinical trials and their consequences
- (2013) Jonathan Rabinowitz et al. SCHIZOPHRENIA RESEARCH
- Converting positive and negative symptom scores between PANSS and SAPS/SANS
- (2013) Theo G.M. van Erp et al. SCHIZOPHRENIA RESEARCH
- Add-on Treatment of Benzoate for Schizophrenia
- (2013) Hsien-Yuan Lane et al. JAMA Psychiatry
- A Multicenter, Add-On Randomized Controlled Trial of Low-Dosed-Serine for Negative and Cognitive Symptoms of Schizophrenia
- (2012) Mark Weiser et al. JOURNAL OF CLINICAL PSYCHIATRY
- Feasibility, Safety and Efficacy of the Combination of D-Serine and Computerized Cognitive Retraining in Schizophrenia: An International Collaborative Pilot Study
- (2012) Deepak C D'Souza et al. NEUROPSYCHOPHARMACOLOGY
- Meta-Analysis of the Efficacy of Adjunctive NMDA Receptor Modulators in Chronic Schizophrenia
- (2011) Surendra P. Singh et al. CNS DRUGS
- Stigmatization of schizophrenia as perceived by nurses, medical doctors, medical students and patients
- (2011) G. SERAFINI et al. Journal of Psychiatric and Mental Health Nursing
- From Revolution to Evolution: The Glutamate Hypothesis of Schizophrenia and its Implication for Treatment
- (2011) Bita Moghaddam et al. NEUROPSYCHOPHARMACOLOGY
- Strategies to Enhance N-Methyl-D-Aspartate Receptor-Mediated Neurotransmission in Schizophrenia, a Critical Review and Meta-Analysis
- (2010) Guochuan Tsai et al. CURRENT PHARMACEUTICAL DESIGN
- A randomized, double-blind, placebo-controlled comparison study of sarcosine ( N-methylglycine) and d-serine add-on treatment for schizophrenia
- (2009) Hsien-Yuan Lane et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2009) David Moher et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- The neurobiology of D-amino acid oxidase and its involvement in schizophrenia
- (2009) L Verrall et al. MOLECULAR PSYCHIATRY
- Once-weekly d-cycloserine effects on negative symptoms and cognition in schizophrenia: An exploratory study
- (2008) D GOFF et al. SCHIZOPHRENIA RESEARCH
- GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
- (2008) Gordon H Guyatt et al. BMJ-British Medical Journal
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now